Premier, INC

Healthcare improvement company Premier, Inc. has completed its acquisition by Patient Square Capital for $2.6 billion, with stockholders receiving $28.25 per share in cash.

Premier, Inc. stockholders overwhelmingly approved the acquisition by an affiliate of Patient Square Capital for $28.25 per share, with the transaction expected to close around November 25, 2025.

Premier Inc. provides additional disclosures for its $28.25 per share acquisition by Patient Square Capital, addressing shareholder litigation.

Premier, Inc. reported a 3% decrease in total net revenue and a significant drop in GAAP net income for Q1 FY2026, while withdrawing future guidance due to its pending acquisition by Patient Square Capital.

Premier Inc. released its 2025 Sustainability Report, highlighting achievements in community health, ethics, supply chain, and environmental stewardship.

Premier, Inc. has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital for $28.25 per share in cash, valuing the transaction at approximately $2.6 billion.

Premier, Inc. reports a significant decrease in net income and revenue for Q1 2026, while progressing towards its acquisition by Patient Square Capital for $28.25 per share.

Premier Inc. reports a decrease in net revenue for Q3 2025, but manages to maintain profitability through cost management and strategic initiatives.

Premier Inc. reports a net loss for Q2 2025, impacted by a goodwill impairment charge and decreased revenue in both Supply Chain and Performance Services segments.

Premier Inc. reports a decrease in revenue for the first quarter of fiscal year 2025, alongside the divestiture of its direct sourcing business.

Premier Inc. reported a net loss for the third quarter of fiscal year 2024, impacted by significant impairment charges, while also detailing ongoing strategic initiatives and a share repurchase program.

Premier Inc.'s Q2 2024 results show a decrease in revenue and adjusted EBITDA, alongside the conclusion of a strategic review and a new share repurchase program.

Premier, Inc. amends its annual report, detailing corporate governance, executive compensation, and disclosing a recent merger agreement.

Premier Inc. reported a significant decrease in net revenue and adjusted EBITDA for fiscal year 2025, driven by strategic divestitures and competitive market pressures, despite ongoing share repurchases.

Premier Inc.'s annual 10-K filing details the company's strategic review, financial results, and risk factors for the fiscal year ended June 30, 2024.

Premier, Inc. President of Supply Chain Services, Bruce J. Radcliff, disposed of shares and had RSUs cancelled following the company's merger into a wholly-owned subsidiary of Premium Parent, LLC.

Premier, Inc. President of Performance Services, David P. Zito, reported the disposition of shares and cancellation of restricted stock units following the company's merger.

Premier, Inc.'s CFO, Glenn Coleman, disposed of Class A Common Stock and had Restricted Stock Units cancelled as part of the company's merger into a wholly-owned subsidiary for $28.25 per share.

Premier, Inc. President & CEO Michael J. Alkire reported the disposition of his Class A Common Stock and cancellation of equity awards following the company's acquisition by Premium Parent, LLC.

Premier Inc.'s General Counsel, David L. Klatsky, reported the disposition of shares and cancellation of restricted stock units following the company's merger into a wholly-owned subsidiary.

Premier, Inc.'s Chief Accounting Officer, Crystal Climer, disposed of Class A Common Stock and restricted stock units following the company's merger into a wholly-owned subsidiary of Premium Parent, LLC.

Premier, Inc. is urging stockholders to vote in favor of the proposed merger with Patient Square Capital at the upcoming Special Meeting.

Premier Inc. filed supplemental disclosures to its definitive proxy statement to address stockholder litigation and demands related to its pending acquisition by Patient Square Capital for $28.25 per share.

Premier, Inc. reminds stockholders to vote FOR the proposed merger with Patient Square Capital at the upcoming Special Meeting on November 21, 2025, emphasizing the Board's unanimous recommendation.

Premier, Inc. is reminding stockholders to vote FOR the proposed merger with Patient Square Capital at the upcoming special meeting on November 21, 2025.

Premier, Inc. stockholders are invited to a special meeting on November 21, 2025, to vote on a definitive merger agreement for its acquisition by Patient Square Capital for $28.25 per share in cash, valuing the company at approximately $2.8 billion.

Premier, Inc. will be acquired by an affiliate of Patient Square Capital for $28.25 per share in cash, valuing the transaction at approximately $2.6 billion.

Dimensional Fund Advisors LP has filed an amended Schedule 13G, reporting no beneficial ownership in Premier Inc's common stock as of December 31, 2025.

State Street Corporation has disclosed a 4.8% beneficial ownership stake in Premier Inc. common stock as of September 30, 2025.

State Street Corporation has disclosed a 5.2% beneficial ownership stake in Premier Inc., holding over 4.2 million shares.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 15.7% beneficial ownership stake in Premier, Inc.'s Class A Stock as of June 30, 2025.

Pacer Funds Trust, Pacer Advisors, Inc., and Joe M. Thomson have jointly filed an amended Schedule 13G, disclosing a combined beneficial ownership of 1.72% of Premier, Inc.'s Class A Common Stock as of March 31, 2025.

Pacer Funds Trust, along with its investment adviser Pacer Advisors, Inc., and Joe M. Thomson, have disclosed a collective beneficial ownership of 5.84% in Premier, Inc.'s Class A Common Stock as of December 31, 2024.